医学信息
醫學信息
의학신식
MEDICAL INFORMATION
2013年
19期
83-84
,共2页
于文霞%王猛%郭瑞卿%李文东%王晓蕴%苏秀海
于文霞%王猛%郭瑞卿%李文東%王曉蘊%囌秀海
우문하%왕맹%곽서경%리문동%왕효온%소수해
复荣通脉胶囊%糖尿病下肢血管病变%纤维蛋白原%超敏C反应蛋白
複榮通脈膠囊%糖尿病下肢血管病變%纖維蛋白原%超敏C反應蛋白
복영통맥효낭%당뇨병하지혈관병변%섬유단백원%초민C반응단백
Fu-Rong Tongmai capsules%Diabetic Lower extremity vascular disease%Fibrinogen%High-sensitivity C-reactive protein
目的观察复荣通脉胶囊对糖尿病下肢血管病变患者纤维蛋白原及超敏 C反应蛋白的影响。方法将80例糖尿病下肢血管病变患者随机分为常规治疗组和复荣通脉胶囊组,常规治疗组,予胰岛素降糖及抗血小板、调脂、降压治疗,复荣通脉胶囊组在常规治疗组基础上,加复荣通脉胶囊5粒,3/d,口服。两组连续用药4 w,观察纤维蛋白原及超敏C反应蛋白的变化。结果复荣通脉胶囊组与常规治疗组相比,能明显降低纤维蛋白原,抑制超敏 C反应蛋白,复荣通脉胶囊对糖尿病患者的血糖无明显影响。结论复荣通脉胶囊对糖尿病下肢血管病变患者,有降低纤维蛋白原和超敏C反应蛋白的作用,推断其抑制血管内皮炎性反应,有抗动脉硬化作用。
目的觀察複榮通脈膠囊對糖尿病下肢血管病變患者纖維蛋白原及超敏 C反應蛋白的影響。方法將80例糖尿病下肢血管病變患者隨機分為常規治療組和複榮通脈膠囊組,常規治療組,予胰島素降糖及抗血小闆、調脂、降壓治療,複榮通脈膠囊組在常規治療組基礎上,加複榮通脈膠囊5粒,3/d,口服。兩組連續用藥4 w,觀察纖維蛋白原及超敏C反應蛋白的變化。結果複榮通脈膠囊組與常規治療組相比,能明顯降低纖維蛋白原,抑製超敏 C反應蛋白,複榮通脈膠囊對糖尿病患者的血糖無明顯影響。結論複榮通脈膠囊對糖尿病下肢血管病變患者,有降低纖維蛋白原和超敏C反應蛋白的作用,推斷其抑製血管內皮炎性反應,有抗動脈硬化作用。
목적관찰복영통맥효낭대당뇨병하지혈관병변환자섬유단백원급초민 C반응단백적영향。방법장80례당뇨병하지혈관병변환자수궤분위상규치료조화복영통맥효낭조,상규치료조,여이도소강당급항혈소판、조지、강압치료,복영통맥효낭조재상규치료조기출상,가복영통맥효낭5립,3/d,구복。량조련속용약4 w,관찰섬유단백원급초민C반응단백적변화。결과복영통맥효낭조여상규치료조상비,능명현강저섬유단백원,억제초민 C반응단백,복영통맥효낭대당뇨병환자적혈당무명현영향。결론복영통맥효낭대당뇨병하지혈관병변환자,유강저섬유단백원화초민C반응단백적작용,추단기억제혈관내피염성반응,유항동맥경화작용。
Objective :To observe the ef ect of Fu-Rong Tongmai capsule on fibrinogen and high-sensitivity C-reactive protein in diabetic patients. Methods:80 patients with diabetic lower extremity vascular disease were randomly divided into conventional treatment group and Fu-Rong Tongmai capsule group. The patients of conventional treatment group were given the thrapy of insulin hypoglycemic, antiplatelet agents, lipid-lowering, antihypertensive. Fu-Rong Tongmai capsule group were added with Take five of the Fu-Rong Tongmai capsule three times daily before meals, on the basis of the conventional treatment. The two groups were given the treatment for 4 weeks. To observe the changes in fibrinogen and high-sensitivity C-reactive protein. Results: Compared to the conventional treatment group, Fu-Rong Tongmai capsule can significantly reduce fibrinogen, inhibition of high-sensitivity C-reactive protein, and had no significant ef ect on the blood sugar in diabetics. Conclusion: Fu-Rong Tongmai capsule can reduce fibrinogen, inhibition of vascular endothelial inflammatory response, anti-atherogenic.